Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV ...

Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates ...

Drs. Yunda Huang, Maria Lemos, Bo Zhang and Karsten Eichholz were recently awarded coveted R01 grants from the National ...

Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential ...

By Ben Ezeamalu and Jennifer Rigby MAKURDI, Nigeria, March 31 (Reuters) - For several months last year, Josephine Angev ...

Global health is evolving rapidly, with breakthroughs turning into medicine. The latest advancement in viral research is ...

Vijayawada: In a significant leap in strengthening the blood safety standards at AIIMS Mangalagiri, the institute is set to inaugurate two new advance.

Nigeria's HIV burden continues to surge despite mitigation measures by experts and industry leaders, as about 20,838 ...

Gilead Sciences is expected to announce its first-quarter results soon, and analysts are projecting single-digit EPS growth.

April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

In a paper published today in the Journal of Clinical Investigation, a research team at Johns Hopkins Medicine and the Johns ...